Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.34 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.33 |
| ▸ | DUT | P33316 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20582419 | 1.00 | HDAC1 (0.40) | HDAC1HDAC6PARP1PARP2SCN5A | |
| SCHEMBL28980756 | 0.89 | PARP1 (0.34) | PARP1PARP2DUT | |
| SCHEMBL30366299 | 0.85 | HDAC1 (0.36) | HDAC1HDAC6PARP1PARP2SCN5A | |
| SCHEMBL21820343 | 0.85 | HDAC1 (0.36) | HDAC1HDAC6PARP1PARP2SCN5A | |
| SCHEMBL30366302 | 0.85 | HDAC1 (0.45) | HDAC1HDAC6SCN5ASCN9A | |
| SCHEMBL21820204 | 0.85 | HDAC1 (0.45) | HDAC1HDAC6SCN5ASCN9A | |
| SCHEMBL21820259 | 0.85 | HDAC1 (0.36) | HDAC1HDAC6PARP1PARP2SCN5A | |
| SCHEMBL30366260 | 0.85 | HDAC1 (0.36) | HDAC1HDAC6PARP1PARP2SCN5A | |
| SCHEMBL20582331 | 0.81 | HDAC1 (0.43) | HDAC1HDAC6SCN5ASCN9A | |
| SCHEMBL30366038 | 0.81 | HDAC1 (0.43) | HDAC1HDAC6SCN5ASCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110382505-B | Heterocyclic compounds useful as antibacterial agents and process for producing the same | 巴格沃克斯研究有限公司 | 2023-04-04 | — | — | CN | disclosed |